TriLink BioTechnologies part of Maravai LifeSciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TriLink BioTechnologies part of Maravai LifeSciences's estimated annual revenue is currently $61.1M per year.(i)
  • TriLink BioTechnologies part of Maravai LifeSciences's estimated revenue per employee is $155,000

Employee Data

  • TriLink BioTechnologies part of Maravai LifeSciences has 394 Employees.(i)
  • TriLink BioTechnologies part of Maravai LifeSciences grew their employee count by -6% last year.

TriLink BioTechnologies part of Maravai LifeSciences's People

NameTitleEmail/Phone
1
vice president commercial operationsReveal Email/Phone
2
SVP GMP OperationsReveal Email/Phone
3
VP Commercial OperationsReveal Email/Phone
4
Director, Facility OperationsReveal Email/Phone
5
Sr. Director Emerging Science and InnovationReveal Email/Phone
6
Director, Analytical ServicesReveal Email/Phone
7
Associate Director Manufacturing, Small Molecule ReagentsReveal Email/Phone
8
Associate Director, Technical DesignReveal Email/Phone
9
Associate Director, ManufacturingReveal Email/Phone
10
Director mRNA ManufacturingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is TriLink BioTechnologies part of Maravai LifeSciences?

Since 1996, TriLink solutions have helped advance drug discovery and biomedical research. TriLink manufactures custom oligonucleotides, modified nucleotides, custom chemistry, and long RNA and mRNA for the diagnostic, therapeutic and OEM markets - complete with cGMP facilities. TriLink holds the patent on a unique Hot Start PCR solution, CleanAmp. Product lines include CleanCap capping technology and CleanTag NGS Library prep. They operate a quality system in compliance with ICH Q7, Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, Section 19, APIs for Use in clinical Trials and ISO 9001 standard.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

394

Number of Employees

$61.1M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TriLink BioTechnologies part of Maravai LifeSciences News

2022-04-17 - Oligonucleotide Synthesis Market 2021 SWOT Study, Sales ...

The major targeted areas of this project are rare genetic disorders, ... Maravai Life Sciences ... TriLink BioTechnologies, LLC.

2022-03-22 - Vector Laboratories Adds Kum Ming Woo to Executive Team ...

... Biosciences and Illumina, Mr. Woo has held positions with Dexcom, Sensient, and TriLink BioTechnologies, a part of Maravai LifeSciences.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$275.6M396-15%$112.7M
#2
$134.7M3993%N/A
#3
N/A40043%N/A
#4
$35M4038%N/A
#5
$67.4M4086%$398M